2021
Management of the Older Patient with Myelodysplastic Syndrome
Shallis RM, Zeidan AM. Management of the Older Patient with Myelodysplastic Syndrome. Drugs & Aging 2021, 38: 751-767. PMID: 34342860, DOI: 10.1007/s40266-021-00881-3.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsMeSH KeywordsAgedHematopoietic Stem Cell TransplantationHumansMyelodysplastic SyndromesQuality of LifeTransplantation ConditioningTransplantation, HomologousConceptsMyelodysplastic syndromeOlder patientsAllogeneic hematopoietic stem cell transplantationHematopoietic stem cell transplantationPrevalence of frailtyMajority of patientsStem cell transplantationPatient-specific factorsDrug-drug interactionsQuality of lifeAbsolute contraindicationPalliative therapyCare therapyCurative therapyIntensive therapyCell transplantationOptimal treatmentSubgroup analysisPatientsPsychosocial issuesSyndromeTherapyPersonalized treatmentAge associatesOlder populationAzacitidine maintenance after allogeneic hematopoietic cell transplantation for MDS and AML
El Chaer F, Borate U, Duléry R, Holtan SG, Law AD, Muffly L, Nassereddine S, Shallis RM, Stringaris K, Taylor J, Devine SM, Mohty M, Hourigan CS. Azacitidine maintenance after allogeneic hematopoietic cell transplantation for MDS and AML. Blood Advances 2021, 5: 1757-1759. PMID: 33755090, PMCID: PMC7993104, DOI: 10.1182/bloodadvances.2020003839.Peer-Reviewed Original ResearchAzacitidineHematopoietic Stem Cell TransplantationHumansLeukemia, Myeloid, AcuteTransplantation, Homologous
2019
Allogeneic stem cell transplantation and combination antiretroviral therapy: cautions, complications, and considerations
Shallis RM, Gleeson S, Azar M, Malinis M, Xu ML, Seropian SE, Gowda L, Zeidan AM. Allogeneic stem cell transplantation and combination antiretroviral therapy: cautions, complications, and considerations. Leukemia & Lymphoma 2019, 60: 2584-2587. PMID: 30943051, DOI: 10.1080/10428194.2019.1594221.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus Statements
2017
Changes in intestinal microbiota and their effects on allogeneic stem cell transplantation
Shallis RM, Terry CM, Lim SH. Changes in intestinal microbiota and their effects on allogeneic stem cell transplantation. American Journal Of Hematology 2017, 93: 122-128. PMID: 28842931, DOI: 10.1002/ajh.24896.Peer-Reviewed Original ResearchMeSH KeywordsGastrointestinal MicrobiomeHematopoietic Stem Cell TransplantationHumansTransplantation ConditioningTransplantation, HomologousConceptsAllogeneic stem cell transplantStem cell transplantCell transplantIntestinal microbiotaAllogeneic hematopoietic stem cell transplantAllogeneic stem cell transplantationHematopoietic stem cell transplantIntestinal immune toleranceStem cell transplantationClostridium difficile infectionDiverse intestinal microbiotaHuman intestinal microbiotaHost diseaseDisease relapseImmune toleranceCell transplantationDifficile infectionIntestinal microbial communitySystemic conditionsAppropriate treatmentMicrobial homeostasisTransplantPathologic statesMajor causeEarly detection